Enabling Successful Sites: Episode 5, Part One: Strategies for improving communication between sites, sponsors and CROs
Investigative sites have shared that one of their top frustrations with the clinical trial process is with the poor communication flow and overall lack of responsiveness from sponsors and CROs. In this episode of ‘Enabling Successful Sites’, Karen McIntyre, Vice President, Global Site Alliances sits down with Jakub Jedrzejewski, Global Project Manager at Future Meds, Iwona Tongbhoyai, Chief Client Solutions Officer at Future Meds and Heidi Juncher-Benzon, Senior Director Clinical Operations for EMEA East at Parexel to discuss the biggest communication challenges facing sites and strategies to resolve them.
Episode 1: Site feasibility and study start-up challenges
Episode 2: Empowering sites to be more inclusive through cultural sensitivity training
Episode 3: Taking the complexity out of oncology clinical trials
Episode 4: Partnering with sites to improve patient recruitment and retention
Related Insights
Article
Key strategies to mitigate the risks of asthma drug development
Jan 24, 2025
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
Reducing technology burdens: How sponsors and CROs can empower sites
Feb 7, 2024
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Playbook
Where better medicines begin
Dec 14, 2022
Video
FSP 2.0: Why Talent Development is the New Talent Acquisition
Oct 26, 2022
Playbook
The upward trend of FSP outsourcing
Sep 29, 2022
Blog
Including patients in DCT design
Sep 13, 2022
Podcast
Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical Depots within a Decentralized Trial Environment
May 9, 2022
Blog
End-to-end risk management: Getting the most from your program
Apr 4, 2022
Related Insights
Article
Key strategies to mitigate the risks of asthma drug development
Jan 24, 2025
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
Reducing technology burdens: How sponsors and CROs can empower sites
Feb 7, 2024
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Playbook
Where better medicines begin
Dec 14, 2022
Video
FSP 2.0: Why Talent Development is the New Talent Acquisition
Oct 26, 2022
Playbook
The upward trend of FSP outsourcing
Sep 29, 2022
Blog
Including patients in DCT design
Sep 13, 2022
Podcast
Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical Depots within a Decentralized Trial Environment
May 9, 2022
Blog
End-to-end risk management: Getting the most from your program
Apr 4, 2022